The battle against the stem cell hype: Are we doing enough? Can the medical and scientific community do more to support regulatory boards in advocating ethical evidence-based medicine?

Richard Joseph Burman


This article highlights the current controversies around stem cell research and its application in clinical medicine. It aims to discuss the ethical concerns around how corporate involvement is corrupting the ethical progression in this field of research. The author appeals to medical and scientific communities to take cognisance of current practices and to facilitate the regulation of new stem cell therapies being advertised to the public.

Author's affiliations

Richard Joseph Burman, Fourth-year medical student, University of Cape Town, South Africa

Full Text



Stem Cells; Ethics; Controversy

Cite this article

South African Journal of Bioethics and Law 2014;7(2):74-75. DOI:10.7196/SAJBL.318

Article History

Date submitted: 2014-03-06
Date published: 2014-11-04

Article Views

Abstract views: 6753
Full text views: 2680

Comments on this article

*Read our policy for posting comments here
View all comments